Arg-gly-asp; Rgd peptide; Arginylglycylaspartic acid; RGD (Arg-Gly-Asp) Peptides; L-Aspartic acid, L-arginylglycyl-; UNII-78VO7F77PN; 78VO7F77PN; CHEMBL313763; (S)-2-(2-((S)-2-amino-5-guanidinopentanamido)acetamido)succinic acid; Rgd tripeptide sequence; Bitiscetin; Bitistatin; Arginyl-glycyl-asparagilin; l-arginylglycylaspartic acid; Poly(rgd); Poly(arg-gly-asp); C12H22N6O6; F-336; N-(N-L-Arginylglycyl)-L-aspartic acid; arginine-glycine-aspartic acid; Tripeptide RGD; L-Arginyl-Glycyl-L-Aspartic acid; Poly (arginyl-glycyl-aspartic acid); Arg-gly-Asp peptide; L-Aspartic acid, N-(N-L-arginylglycyl)-; SCHEMBL19139; CTK8D8707; AOB5939; DTXSID30912420; Arg-Gly-Asp, >=97% (TLC); HY-P0278; KS-00000XS3; ZINC3922521; 2226AH; BDBM50107402; MFCD00057952; s8008; AKOS015854089; AKOS015902678; CCG-267987; NCGC00167210-01; AC-32859; AS-61345; Q4068819; L-Aspartic acid, N-(N-L-arginylglycyl)-, homopolymer; 2-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-succinic acid(RGD); (2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}butanedioic acid; (S)-2-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-succinic acid